Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity

NCT00845338 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class

Stopped The enrollment rate at most centers was unlikely to result in the recruitment of the planned sample size of 40 evaluable subjects.

Conditions

Interventions

Sponsor

Bayer